Clinical Trials on Eluted Swab

Total 49625 results

Masimo Corporation

Enrolling by invitation

Impact of Bridge™ Device to Treat Opioid Withdrawal Symptoms

Opioid Use Disorder

United States
Carilion Clinic

Completed

START NOW in the Treatment of Opioid Addicted Individuals

Opioid Use Disorder

United States
Mclean Hospital
National Institute on Drug Abuse (NIDA)

Terminated

A Mobile Executive Functioning Intervention for Momentary Craving in Opioid Use Disorders

Opioid Use Disorder

United States
Butler Hospital

Withdrawn

Changing Opioid Users' Negative Attitudes Toward Medication Assisted Treatment

Opioid Use Disorder

United States
Novartis Pharmaceuticals

Completed

Study to Investigate Whether AFQ056 Reduces Cocaine Use in Patients Diagnosed With Cocaine Use Disorder (CUD)

Cocaine-related Disorder

Spain, Argentina, Switzerland
Dartmouth-Hitchcock Medical Center

Completed

MySafeRx™: An Integrated Mobile Platform for Buprenorphine Adherence (MySafeRx)

Opioid Use Disorder

United States
Astellas Pharma Global Development, Inc.
National Institute on Drug Abuse (NIDA)

Completed

A Study to Assess the Safety, Tolerability and Pharmacokinetics of Multiple Doses of ASP8062 With a Single Dose of Morphine in Recreational Opioid Using Participants

Opioid Use Disorder

United States
Ohio State University

Withdrawn

Long Acting Subcutaneous vs Short Acting Sublingual Buprenorphine in Pregnant and Lactating Women

Opioid Use Disorder

United States
Friends Research Institute, Inc.
National Institute on Drug Abuse (NIDA); Laura and John Arnold Foundation

Completed

A Randomized Trial of Interim Methadone and Patient Navigation Initiated in Jail (SOMATICS FRI)

Opioid Use Disorder

United States
NYU Langone Health
National Institute on Drug Abuse (NIDA); The Emmes Company, LLC

Completed

Extended-Release Naltrexone vs. Buprenorphine for Opioid Treatment

Opioid Use Disorder

United States
Yale University
National Institute on Drug Abuse (NIDA)

Completed

Buprenorphine Maintenance Dose Schedule and Treatment Setting - 2

Substance-Related Disorders | Opioid-Related Disorders

United States
Kyle Kampman
National Institute on Alcohol Abuse and Alcoholism (NIAAA)

Completed

Topiramate for Alcohol and Cocaine Dependence (TOP2)

Alcoholism | Cocaine Dependence

United States
Yale University
National Institute on Drug Abuse (NIDA); VA Connecticut Healthcare System

Completed

Novel Medications for Opiate Detoxification - 4

Substance-Related Disorders | Opioid-Related Disorders

United States
NYU Langone Health

Completed

TAU Opioid Use Outcomes Following Discharge From Detoxification and Short Term Residential Programs Affiliated With CTN-0051

Opioid Use Disorder

United States
University of Pennsylvania
National Institute on Drug Abuse (NIDA)

Terminated

Vigabatrin for Cocaine and Alcohol Dependence (VGB)

Alcoholism | Cocaine Dependence

United States
Alkermes, Inc.

Completed

Evaluating Naltrexone for Use in Conjunction With Buprenorphine in Adults With Opioid Use Disorder Transitioning From Buprenorphine Maintenance Prior to First Dose of VIVITROL

Opioid Use Disorder

United States
University of North Carolina, Chapel Hill
National Institute on Drug Abuse (NIDA)

Completed

Sex and Female Empowerment (SAFE)

Opioid Use Disorder

United States
New York State Psychiatric Institute
National Institute on Drug Abuse (NIDA)

Completed

Prescription Opioid Effects in Abusers Versus Non-Abusers

Substance-Related Disorders | Opioid-Related Disorders

United States
National Institute on Drug Abuse (NIDA)
Cincinnati MDRU

Completed

Buprenorphine/Naloxone for Opiate-Dependence Treatment - 1

Substance-Related Disorders | Opioid-Related Disorders

United States
National Institute on Drug Abuse (NIDA)
University of Pennsylvania

Completed

Evaluation of L-alpha-acetylmethadol (LAAM) in Methadone Patients - 5

Substance-Related Disorders | Opioid-Related Disorders

United States
National Institute on Drug Abuse (NIDA)
Yale University

Completed

Buprenorphine Maintenance Dose Schedule and Treatment Setting - 1

Substance-Related Disorders | Opioid-Related Disorders

United States
National Institute on Drug Abuse (NIDA)
University of Pennsylvania

Completed

Effects of Buprenorphine and Naloxone in Opiate Addicts - 4

Substance-Related Disorders | Opioid-Related Disorders

United States
Indivior Inc.

Completed

Single-dose, Study of RBP-6000 in Opioid Dependent Individuals

Opioid Use Disorder

United States
University of Pennsylvania
National Institute on Drug Abuse (NIDA)

Completed

Naltrexone in Two Models of Psychosocial Treatments for Cocaine and Alcohol Dependence - 1

Alcoholism | Cocaine Dependence

United States
Parc de Salut Mar
Instituto de Salud Carlos III

Completed

Mephedrone and Alcohol Interactions in Humans

Alcohol-Related Disorders | Amphetamine-Related Disorders

Spain
University of Chicago
National Institute on Drug Abuse (NIDA)

Completed

Reinforcing Effects of Brief Exposures to Nitrous Oxide - 8

Substance-Related Disorders | Opioid-Related Disorders

United States
University of Chicago
National Institute on Drug Abuse (NIDA)

Completed

Effects of Subanesthetic Concentrations of Nitrous Oxide - 1

Substance-Related Disorders | Opioid-Related Disorders

United States
University of Chicago
National Institute on Drug Abuse (NIDA)

Completed

Effects of Combined Alcohol and Nitrous Oxide Intake - 15

Substance-Related Disorders | Opioid-Related Disorders

United States
University of Chicago
National Institute on Drug Abuse (NIDA)

Completed

Effects of Behavioral Contingencies on Effects of Nitrous Oxide - 12

Substance-Related Disorders | Opioid-Related Disorders

United States
University of Chicago
National Institute on Drug Abuse (NIDA)

Completed

Subjective Effects of Nitrous Oxide in Dental Patients - 17

Substance-Related Disorders | Opioid-Related Disorders

United States
University Hospital Freiburg

Completed

Evaluation of Case Management to Improve the Outpatient Care of Alcohol-related Disorders

Alcohol-related Disorders

Germany
Cambridge Health Alliance
National Center for Complementary and Integrative Health (NCCIH)

Completed

MINDFUL-OBOT: Effect of Mindfulness on Opioid Use and Anxiety During Primary Care Buprenorphine Treatment

Depression | Anxiety | Opioid-use Disorder | Stress Related Disorder

United States
University of Michigan
National Institute on Drug Abuse (NIDA)

Not yet recruiting

Adversity, Brain and Opioid Use Study

Healthy | Opioid Use Disorder

United States
University of Arkansas

Enrolling by invitation

Pharmacist-Led Interventions to Increase Access to Medications for Opioid Use Disorders (PLI-MOUD) (PLI-MOUD)

Opioid Use Disorder | Overdose

United States
University of North Carolina, Chapel Hill

Completed

Oxytocin Treatment of Opioid Dependence

Opioid Dependence | Opioid Withdrawal

United States
New York State Psychiatric Institute
National Institute on Drug Abuse (NIDA)

Completed

Memantine as a Supplement to Naltrexone in Treating Heroin Dependence (NAMHS)

Heroin Dependence | Opioid Dependence

United States
National Institute on Alcohol Abuse and Alcoholism...
University of Pittsburgh

Completed

Drug Treatment for Alcoholics With Bipolar Disorder

Alcoholism | Bipolar Disorder

United States
New York State Psychiatric Institute
National Institute on Drug Abuse (NIDA)

Completed

Behavioral Naltrexone Therapy for Promoting Adherence to Oral Naltrexone vs Extended Release Injectable Depot Naltrexone (Depot-BNT)

Heroin Dependence | Opiate Dependence

United States
Johns Hopkins University
National Institute on Drug Abuse (NIDA)

Completed

A Within Subject Comparison of Opioid Withdrawal in Opioid Dependent Individuals

Opioid Dependence | Opioid Abuse

United States
National Institute on Drug Abuse (NIDA)
New York MDRU

Completed

Buprenorphine/Naloxone in the Treatment of Heroin Dependence - 14

Substance-Related Disorders | Opioid Dependence

United States
National Institute on Drug Abuse (NIDA)
University of Texas

Completed

Buprenorphine as a Treatment for Individuals Dependent on Analgesic Opioids

Opioid-Related Disorders

United States
Shanghai Mental Health Center
Shanghai Center of Biomedicine Development

Completed

Efficacy Evaluation of Traditional Chinese Medicine JITAI Combined Comprehensive Model Among Heroin Addicts After Detoxification

Heroin Addiction

China
University of Luebeck
German Federal Ministry of Education and Research

Completed

Alcohol Expert System Intervention for Problematic Alcohol Use

Alcohol Drinking | Alcohol-related Disorders

Germany
University of California, Los Angeles

Completed

Optimizing Outcomes Using Suboxone for Opiate Dependence (OpBup)

Opioid Dependency

United States
Cambridge Health Alliance
National Center for Complementary and Integrative Health (NCCIH)

Completed

Effect of Mindfulness on Opioid Use and Anxiety During Primary Care Buprenorphine Treatment (R33 Phase) (Mindful-OBOT)

Depression | Anxiety | Opioid-use Disorder | Stress Related Disorder

United States
Trustees of Dartmouth College
Patient-Centered Outcomes Research Institute

Completed

MOms in REcovery (MORE) Study: Defining Optimal Care (MORE)

Opioid-Related Disorders | Substance Use Disorders | NAS

United States
University of Pennsylvania

Completed

Biomarkers of Injectable Extended Release Naltrexone Treatment

Heroin Dependence | Opioid Dependence

United States
University of Minnesota
National Institute on Drug Abuse (NIDA)

Completed

Combining Neuro-Imaging and Non-Invasive Brain Stimulation for Clinical Intervention in Opioid Use Disorder

Opioid-Related Disorders | Heroin Dependence | Morphine Dependence

United States
Hurd,Yasmin, Ph.D.
Jazz Pharmaceuticals

Completed

Acute and Short-term Effects of CBD on Cue-induced Craving in Drug-abstinent Heroin-dependent Humans

Opiate Addiction

United States
University of Arkansas
National Institute on Drug Abuse (NIDA)

Completed

Improving Treatment Outcomes for Prescription Opioid Dependence (GBN)

Drug Dependence

United States

Clinical Trials on Eluted Swab

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Tunisia

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations